| | Varia. | Varia. 5d. | Varia. 1 de ene. | Varia. 1 año | Varia. 3 años | Capi. (M$) |
 | PROTAGONIST THERAPEUTICS, INC. | -1.98% | -14.95% | -76.87% | -82.38% | -34.68% | 385 |
| | | | | | | |
| MODERNA, INC. | 0.03% | -0.29% | -43.76% | -39.21% | 875.75% | 56 820 |
| IQVIA HOLDINGS INC. | 1.35% | 2.58% | -23.09% | -10.45% | 34.86% | 41 072 |
 | LONZA GROUP AG | 0.71% | 4.30% | -32.69% | -22.00% | 53.43% | 39 547 |
| SEAGEN INC. | -1.18% | 1.69% | 14.45% | 12.07% | 155.66% | 32 570 |
 | CELLTRION, INC. | 1.42% | 4.08% | -9.85% | -32.19% | -5.11% | 19 048 |
| ALNYLAM PHARMACEUTICALS, INC. | 0.29% | -0.31% | -13.99% | -13.96% | 101.01% | 17 621 |
| ICON PUBLIC LIMITED COMPANY | -0.26% | -0.36% | -30.03% | 4.83% | 40.74% | 17 616 |
 | PHARMARON BEIJING CO., LTD. | 0.91% | 2.38% | 1.10% | -34.18% | 317.88% | 16 084 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | 3.11% | 9.56% | -10.45% | -40.79% | 122.67% | 14 097 |
| BIO-TECHNE CORPORATION | -0.53% | 0.39% | -33.00% | -23.01% | 66.26% | 13 600 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -2.50% | -3.00% | -43.21% | -42.16% | 50.79% | 10 871 |
| QIAGEN N.V. | 1.11% | 5.29% | -15.08% | -2.44% | 16.40% | 10 736 |
| UNITED THERAPEUTICS CORPORATION | -1.11% | -2.17% | 9.05% | 31.34% | 201.87% | 10 674 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.04% | 1.05% | 5.73% | 50.09% | 232.75% | 10 352 |
 | GENSCRIPT BIOTECH CORPORATION | 1.61% | 4.79% | -17.54% | -16.08% | 45.01% | 7 656 |
| | | | | | | |
| | Promedio | 0.33% | 2.00% | -16.16% | -11.88% | 154.00% | |
| | Media ponderada por Capi. | 0.35% | 1.91% | -20.13% | -16.02% | 232.93% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Reporte
